Drugs marked in yellow have text description.
- AMGEVITA /solution/: adalimumab (50)
- AMGEVITA /solution/: adalimumab (50)
- AMGEVITA /solution/: adalimumab (50)
- ARANESP /solution/: darbepoetin alfa (500)
- ARANESP /solution/: darbepoetin alfa (25)
- ARANESP /solution/: darbepoetin alfa (40)
- ARANESP /solution/: darbepoetin alfa (100)
- ARANESP /solution/: darbepoetin alfa (200)
- ARANESP /solution/: darbepoetin alfa (200)
- ARANESP /solution/: darbepoetin alfa (200)
- ARANESP /solution/: darbepoetin alfa (200)
- ARANESP /solution/: darbepoetin alfa (500)
- ARANESP /solution/: darbepoetin alfa (500)
- ARANESP /solution/: darbepoetin alfa (500)
- ARANESP /solution/: darbepoetin alfa (100)
- ARANESP /solution/: darbepoetin alfa (100)
- AVSOLA /powder for solution/: infliximab (100)
- BLINCYTO /powder for solution/: blinatumomab (38.5)
- EVENITY /solution/: romosozumab (105)
- KANJINTI /kit, powder for solution/: trastuzumab (420)
- KANJINTI /powder for solution/: trastuzumab (150)
- KYPROLIS /powder for solution/: carfilzomib (60)
- KYPROLIS /powder for solution/: carfilzomib (10)
- KYPROLIS /powder for solution/: carfilzomib (30)
- LUMAKRAS /tablet/: sotorasib (120)
- MVASI /solution/: bevacizumab (25)
- MVASI /solution/: bevacizumab (25)
- NEULASTA /solution/: pegfilgrastim (10)
- NEUPOGEN /solution/: filgrastim (300)
- NEUPOGEN /solution/: filgrastim (600)
- NEUPOGEN /solution/: filgrastim (600)
- NPLATE /powder for solution/: romiplostim (250)
- NPLATE /powder for solution/: romiplostim (500)
- OTEZLA /tablet/: apremilast (30)
- OTEZLA /tablet/: apremilast (10), apremilast (20), apremilast (30)
- PROLIA /solution/: denosumab (60)
- REPATHA /solution/: evolocumab (120)
- REPATHA /solution/: evolocumab (140)
- SENSIPAR /tablet/: cinacalcet (30)
- SENSIPAR /tablet/: cinacalcet (90)
- SENSIPAR /tablet/: cinacalcet (60)
- VECTIBIX /solution/: panitumumab (400)
- VECTIBIX /solution/: panitumumab (100)
- WEZLANA /solution/: ustekinumab (90)
- WEZLANA /solution/: ustekinumab (45)
- WEZLANA /solution/: ustekinumab (45)
- WEZLANA I.V. /solution/: ustekinumab (5)
- XGEVA /solution/: denosumab (120)
Found 48 matches.